A newly developed drug stabilizes dopamine and serotonin levels using a novel mechanism. It effectively treats psychosis in patients with schizophrenia, and researchers are testing its efficacy for Parkinson’s disease as well.
Spending an hour every day listening to a low-pitched thrum and gazing at blinking lights may help prevent structural changes in the brain and cognitive impairments associated with Alzheimer’s disease.
Researchers plan to monitor the immune responses of COVID-19 patients for one year to see how they correlate with illness severity and lasting effects. This data will help develop personalized treatments for patients.
Unlike other cells in the body that mount a strong immune response against microbial invaders, skin cells use an epigenetic mechanism to ignore most of the microbes they see. These findings reveal a potential new drug target for inflammatory skin diseases.
A naturally occurring nanoparticle yields a new type of vaccine that offers broad-acting protection against emerging SARS-CoV-2 variants. With further development, the approach may lead to a pan-coronavirus vaccine.
A native Hawaiian, anthropologist, and genome scientist, Keolu Fox investigates how mutations found in indigenous populations contribute to human health and emphasizes the importance of considering who benefits from research involving indigenous genomes.